Matthias Gijsen

516 total citations
32 papers, 307 citations indexed

About

Matthias Gijsen is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Matthias Gijsen has authored 32 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 17 papers in Epidemiology and 8 papers in Molecular Medicine. Recurrent topics in Matthias Gijsen's work include Antibiotics Pharmacokinetics and Efficacy (25 papers), Pneumonia and Respiratory Infections (10 papers) and Antibiotic Resistance in Bacteria (8 papers). Matthias Gijsen is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (25 papers), Pneumonia and Respiratory Infections (10 papers) and Antibiotic Resistance in Bacteria (8 papers). Matthias Gijsen collaborates with scholars based in Belgium, Netherlands and Sweden. Matthias Gijsen's co-authors include Isabel Spriet, Erwin Dreesen, Ruth Van Daele, Joost Wauters, Yves Debaveye, Marc Ferrante, Pieter Annaert, Karel Allegaert, Dirk Vlasselaers and Philippe Meersseman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Critical Care Medicine and Pharmaceutical Research.

In The Last Decade

Matthias Gijsen

28 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Gijsen Belgium 11 218 115 59 53 45 32 307
Evelyn Dhont Belgium 9 231 1.1× 124 1.1× 42 0.7× 55 1.0× 47 1.0× 30 340
Anka C. Roehr Germany 9 236 1.1× 131 1.1× 62 1.1× 67 1.3× 48 1.1× 13 290
Fabio Taccone Belgium 10 242 1.1× 178 1.5× 69 1.2× 89 1.7× 58 1.3× 24 386
Sahand Imani Australia 6 246 1.1× 158 1.4× 71 1.2× 39 0.7× 83 1.8× 11 308
D. Matthew Shoemaker United States 5 176 0.8× 86 0.7× 61 1.0× 74 1.4× 41 0.9× 10 301
Sofie Dhaese Belgium 11 214 1.0× 155 1.3× 90 1.5× 18 0.3× 85 1.9× 19 299
S. Christian Cheatham United States 10 255 1.2× 125 1.1× 87 1.5× 41 0.8× 79 1.8× 14 439
Yue‐E Wu China 10 155 0.7× 90 0.8× 33 0.6× 22 0.4× 24 0.5× 46 315
Ryan L. Crass United States 12 315 1.4× 132 1.1× 136 2.3× 160 3.0× 68 1.5× 33 485
Jean-Baptiste Gordien France 8 215 1.0× 159 1.4× 84 1.4× 78 1.5× 35 0.8× 9 386

Countries citing papers authored by Matthias Gijsen

Since Specialization
Citations

This map shows the geographic impact of Matthias Gijsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Gijsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Gijsen more than expected).

Fields of papers citing papers by Matthias Gijsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Gijsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Gijsen. The network helps show where Matthias Gijsen may publish in the future.

Co-authorship network of co-authors of Matthias Gijsen

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Gijsen. A scholar is included among the top collaborators of Matthias Gijsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Gijsen. Matthias Gijsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spriet, Isabel, Matthias Gijsen, Veerle Foulon, et al.. (2024). Check of APpropriaTeness of Antimicrobial therapy In Nursing homes (CAPTAIN):a point prevalence study in Belgium. JAC-Antimicrobial Resistance. 6(4). dlae101–dlae101.
2.
Dreesen, Erwin, Matthias Gijsen, Stefanie Desmet, et al.. (2024). Decreased Kidney Function Explains Higher Vancomycin Exposure in Older Adults. Drugs & Aging. 41(9). 753–762. 1 indexed citations
3.
Parrott, Neil, et al.. (2024). Physiologically-based pharmacokinetic modelling in sepsis: A tool to elucidate how pathophysiology affects meropenem pharmacokinetics. International Journal of Antimicrobial Agents. 64(6). 107352–107352. 4 indexed citations
4.
Laenen, Annouschka, Pieter Vermeersch, Glynis Frans, et al.. (2024). Human serum albumin: prediction model and reference values for preterm and term neonates. Pediatric Research. 99(2). 604–611. 1 indexed citations
5.
Gijsen, Matthias, Johan Maertens, Wim Van Paesschen, et al.. (2024). Ceftazidime-related neurotoxicity in a patient with renal impairment: a case report and literature review. Infection. 52(3). 1113–1123. 3 indexed citations
6.
Gijsen, Matthias, Willy Peetermans, Eric Van Wijngaerden, et al.. (2024). Evaluation and implementation of optimized antimicrobial dosing strategies in obese and underweight patients. Infection. 52(6). 2297–2314.
7.
Güiza, Fabián, Matthias Gijsen, Isabel Spriet, et al.. (2023). External Validation of the Augmented Renal Clearance Predictor in Critically Ill COVID-19 Patients. Antibiotics. 12(4). 698–698. 2 indexed citations
8.
Qi, Bing, et al.. (2023). Unravelling the Hepatic Elimination Mechanisms of Colistin. Pharmaceutical Research. 40(7). 1723–1734. 1 indexed citations
9.
Dreesen, Erwin, Joost Wauters, Philippe Meersseman, et al.. (2023). Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review. Antibiotics. 12(7). 1085–1085. 9 indexed citations
10.
Ewoldt, Tim M. J., Matthias Gijsen, Nestor Parolya, et al.. (2023). Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) Models. Antibiotics. 12(12). 1674–1674. 4 indexed citations
11.
Gijsen, Matthias, Pieter Annaert, Ruth Van Daele, et al.. (2022). Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal Function. SHILAP Revista de lepidopterología. 18 indexed citations
12.
Dreesen, Erwin, Sebastian G. Wicha, Karel Allegaert, et al.. (2022). Systematic Comparison of Hospital-Wide Standard and Model-Based Therapeutic Drug Monitoring of Vancomycin in Adults. Pharmaceutics. 14(7). 1459–1459. 4 indexed citations
13.
Gijsen, Matthias, Pieter Annaert, Yves Debaveye, et al.. (2021). Meropenem Stability in Human Plasma at −20 °C: Detailed Assessment of Degradation. Antibiotics. 10(4). 449–449. 10 indexed citations
14.
Gijsen, Matthias, Dirk Vlasselaers, Isabel Spriet, & Karel Allegaert. (2021). Pharmacokinetics of Antibiotics in Pediatric Intensive Care: Fostering Variability to Attain Precision Medicine. Antibiotics. 10(10). 1182–1182. 23 indexed citations
15.
Gijsen, Matthias, Johan Maertens, Katrien Lagrou, et al.. (2021). Prospective assessment of breakthrough infections and neurotoxicity and their association with cefepime trough concentrations in patients with febrile neutropenia. International Journal of Antimicrobial Agents. 59(1). 106472–106472. 13 indexed citations
16.
17.
18.
Daele, Ruth Van, et al.. (2020). Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs?. Frontiers in Pharmacology. 11. 620–620. 81 indexed citations
19.
Gijsen, Matthias, Johan Maertens, Katrien Lagrou, et al.. (2020). Cefepime therapeutic drug monitoring: Evaluation of agreement between peripheral and central venous blood sampling. Clinica Chimica Acta. 510. 450–454. 1 indexed citations
20.
Gijsen, Matthias, Marine Flechet, Ruth Van Daele, et al.. (2020). Development and External Validation of an Online Clinical Prediction Model for Augmented Renal Clearance in Adult Mixed Critically Ill Patients: The Augmented Renal Clearance Predictor. Critical Care Medicine. 48(12). e1260–e1268. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evelyn Dhont Breakdown of academic impact, for papers by Anka C. Roehr Breakdown of academic impact, for papers by Fabio Taccone Breakdown of academic impact, for papers by Sahand Imani Breakdown of academic impact, for papers by D. Matthew Shoemaker Breakdown of academic impact, for papers by Sofie Dhaese Breakdown of academic impact, for papers by S. Christian Cheatham Breakdown of academic impact, for papers by Yue‐E Wu Breakdown of academic impact, for papers by Ryan L. Crass Breakdown of academic impact, for papers by Jean-Baptiste Gordien
Rankless by CCL
2026